Considerations about a new syndrome (AIDS) and blood transfusions or fractions and their impact on our environment
DOI:
https://doi.org/10.53591/rug.v55i1.1223Abstract
In August 1983, a news item appeared in the media of our country, which produced great expectations at all levels of the population, especially among homosexual individuals, to whom special reference was made in the news. On March 4, 1983, an article appeared in M. M. W. R. (Morbidity And Mortality Weekly Report) in which reference was made to 1,200 cases reported in the U.S. of a new high mortality disease, AIDS. More than 450 people had died due to this pathology, including people with Kaposi's Sarcoma, drug addicts who abused injections, infections by some opportunistic parasites such as protozoa, helminths, fungi, bacteria and viruses, which reduce the resistance of these individuals leading to acute immunodeficiency syndrome and in homosexual and bisexual individuals, and some Haitian immigrants, which caused great alarm throughout the world.
References
Office of Biologics FDA Recomendations on AIDS (3 me. morandum of March 25, 1.983).
M.M.W.R. (March 4, 1.983).
ARC./AA. BB./C C B C Joint Statement on Prevention of AIDS Related to transfusión (March 7, 1.983).
Sample Letter to Hospital Physicians 5) HHS Release (March 25, 1.983).
Published
How to Cite
Issue
Section
License
![Creative Commons License](http://i.creativecommons.org/l/by-nc-nd/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0. International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes .
- NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.